1 31/10/2023 2023-10-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2022-11-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12278205 2022-11-01 2023-10-31 12278205 2023-10-31 12278205 2022-10-31 12278205 2021-11-01 2022-10-31 12278205 2022-10-31 12278205 2021-10-31 12278205 bus:RegisteredOffice 2022-11-01 2023-10-31 12278205 bus:LeadAgentIfApplicable 2022-11-01 2023-10-31 12278205 bus:Director1 2022-11-01 2023-10-31 12278205 bus:Director2 2022-11-01 2023-10-31 12278205 core:WithinOneYear 2023-10-31 12278205 core:WithinOneYear 2022-10-31 12278205 bus:Director1 2022-10-31 12278205 bus:Director1 2023-10-31 12278205 bus:Director2 2022-10-31 12278205 bus:Director2 2023-10-31 12278205 bus:Director1 2021-10-31 12278205 bus:Director1 2022-10-31 12278205 bus:Director2 2021-10-31 12278205 bus:Director2 2022-10-31 12278205 bus:Director1 2021-11-01 2022-10-31 12278205 bus:Director2 2021-11-01 2022-10-31 12278205 bus:Micro-entities 2022-11-01 2023-10-31 12278205 bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 12278205 bus:FullAccounts 2022-11-01 2023-10-31 12278205 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 12278205 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31
Company registration number: 12278205
Vanstone Medical Ltd
Unaudited filleted financial statements
31 October 2023
Vanstone Medical Ltd
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Vanstone Medical Ltd
Directors and other information
Directors Dr R Vanstone
Dr N Vanstone
Company number 12278205
Registered office 1 Boston Close
Oreston
Plymouth
PL9 7NR
Business address 1 Boston Close
Oreston
Plymouth
PL9 7NR
Accountants Franklins Accountants LLP
Astor House
2 Alexandra Road
Mutley Plain
Plymouth
PL4 7JR
Vanstone Medical Ltd
Statement of financial position
31 October 2023
2023 2022
£ £ £ £
Fixed assets 5,716 4,721
_______ _______
Current assets 31,072 22,440
Prepayments and accrued income 147 140
_______ _______
31,219 22,580
Creditors: amounts falling due within one year ( 8,909) ( 6,812)
_______ _______
Net current assets 22,310 15,768
_______ _______
Total assets less current liabilities 28,026 20,489
_______ _______
Net assets 28,026 20,489
_______ _______
Capital and reserves 28,026 20,489
_______ _______
Notes to the financial statements
Vanstone Medical Ltd
Year ended 31 October 2023
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
2. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2023
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr R Vanstone ( 121) 1,101 ( 1,000) ( 20)
Dr N Vanstone ( 121) 30,501 ( 30,400) ( 20)
_______ _______ _______ _______
( 242) 31,602 ( 31,400) ( 40)
_______ _______ _______ _______
2022
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr R Vanstone ( 5,747) 9,626 ( 4,000) ( 121)
Dr N Vanstone ( 5,747) 35,776 ( 30,150) ( 121)
_______ _______ _______ _______
( 11,494) 45,402 ( 34,150) ( 242)
_______ _______ _______ _______
The directors have loaned the company £40.28 at the year end date, the loan is interest free and repayable in less than one year.
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 13 February 2024 , and are signed on behalf of the board by:
Dr R Vanstone
Director
The company is a private company limited by shares, registered in England.